These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 25441487)
1. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients. Gandra S; Barysauskas CM; Mack DA; Barton B; Finberg R; Ellison RT J Hosp Infect; 2014 Nov; 88(3):170-6. PubMed ID: 25441487 [TBL] [Abstract][Full Text] [Related]
2. The discontinuation of contact precautions for methicillin-resistant Schrank GM; Snyder GM; Davis RB; Branch-Elliman W; Wright SB BMJ Qual Saf; 2020 Oct; 29(10):1-2. PubMed ID: 31320496 [TBL] [Abstract][Full Text] [Related]
3. Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE. Martin EM; Bryant B; Grogan TR; Rubin ZA; Russell DL; Elashoff D; Uslan DZ Infect Control Hosp Epidemiol; 2018 Jul; 39(7):788-796. PubMed ID: 29745356 [TBL] [Abstract][Full Text] [Related]
4. Can we reduce contact precautions days for methicillin-resistant Staphylococcus aureus and vancomycin resistant Enterococcus infected patients? Thottacherry ED; Hassoun A J Infect Public Health; 2020 Aug; 13(8):1118-1122. PubMed ID: 32336607 [TBL] [Abstract][Full Text] [Related]
5. Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients. Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM Infect Control Hosp Epidemiol; 2009 Feb; 30(2):130-8. PubMed ID: 19128183 [TBL] [Abstract][Full Text] [Related]
6. Impact of Discontinuing Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: An Interrupted Time Series Analysis. Bearman G; Abbas S; Masroor N; Sanogo K; Vanhoozer G; Cooper K; Doll M; Stevens MP; Edmond MB Infect Control Hosp Epidemiol; 2018 Jun; 39(6):676-682. PubMed ID: 29580304 [TBL] [Abstract][Full Text] [Related]
7. Association of hospital contact precaution policies with emergency department admission time. Kotkowski K; Ellison RT; Barysauskas C; Barton B; Allison J; Mack D; Finberg RW; Reznek M J Hosp Infect; 2017 Jul; 96(3):244-249. PubMed ID: 28454768 [TBL] [Abstract][Full Text] [Related]
8. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Morgan DJ; Murthy R; Munoz-Price LS; Barnden M; Camins BC; Johnston BL; Rubin Z; Sullivan KV; Shane AL; Dellinger EP; Rupp ME; Bearman G Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1163-72. PubMed ID: 26138329 [TBL] [Abstract][Full Text] [Related]
9. Intervention to reduce transmission of resistant bacteria in intensive care. Huskins WC; Huckabee CM; O'Grady NP; Murray P; Kopetskie H; Zimmer L; Walker ME; Sinkowitz-Cochran RL; Jernigan JA; Samore M; Wallace D; Goldmann DA; N Engl J Med; 2011 Apr; 364(15):1407-18. PubMed ID: 21488763 [TBL] [Abstract][Full Text] [Related]
10. Value of an active surveillance policy to document clearance of meticillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci amongst inpatients with prolonged admissions. Ghosh A; Jiao L; Al-Mutawa F; O'Neill C; Mertz D; J Hosp Infect; 2014 Dec; 88(4):230-3. PubMed ID: 25458743 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals. Simor AE; Williams V; McGeer A; Raboud J; Larios O; Weiss K; Hirji Z; Laing F; Moore C; Gravel D; Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Bardossy AC; Alsafadi MY; Starr P; Chami E; Pietsch J; Moreno D; Johnson L; Alangaden G; Zervos M; Reyes K Am J Infect Control; 2017 Dec; 45(12):1369-1371. PubMed ID: 28843943 [TBL] [Abstract][Full Text] [Related]
13. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation. Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379 [TBL] [Abstract][Full Text] [Related]
14. Discontinuing MRSA and VRE contact precautions: Defining hospital characteristics and infection prevention practices predicting safe de-escalation. Martin EM; Colaianne B; Bridge C; Bilderback A; Tanner C; Wagester S; Yassin M; Pontzer R; Snyder GM Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1595-1602. PubMed ID: 34847970 [TBL] [Abstract][Full Text] [Related]
15. Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study. Martin EM; Russell D; Rubin Z; Humphries R; Grogan TR; Elashoff D; Uslan DZ Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1323-1330. PubMed ID: 27457254 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Wang Z; Cao B; Liu YM; Gu L; Wang C Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Intensive Care Units. Khader K; Thomas A; Huskins WC; Stevens V; Keegan LT; Visnovsky L; Samore MH Clin Infect Dis; 2021 Jan; 72(Suppl 1):S42-S49. PubMed ID: 33512528 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients. Kim YJ; Kim SI; Choi JY; Yoon SK; You YK; Kim DG Korean J Intern Med; 2015 Sep; 30(5):694-704. PubMed ID: 26354064 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital. Popiel KY; Miller MA Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209 [TBL] [Abstract][Full Text] [Related]
20. Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies. Almyroudis NG; Osawa R; Samonis G; Wetzler M; Wang ES; McCarthy PL; Segal BH Infect Control Hosp Epidemiol; 2016 Apr; 37(4):398-403. PubMed ID: 26750087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]